Simon Grumett

1.4k total citations
12 papers, 228 citations indexed

About

Simon Grumett is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Simon Grumett has authored 12 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Simon Grumett's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Frailty in Older Adults (2 papers). Simon Grumett is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Frailty in Older Adults (2 papers). Simon Grumett collaborates with scholars based in United Kingdom and Serbia. Simon Grumett's co-authors include David Kerr, Aman S. Coonar, Jurjees Hasan, Vernon T. Farewell, Rachel Kerr, Joel Dunning, Patrick Julier, Janet Dunn, Elaine Johnstone and Norman Williams and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Colorectal Disease.

In The Last Decade

Simon Grumett

10 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Grumett United Kingdom 5 121 108 63 38 30 12 228
Elisa Pellegrini Italy 10 92 0.8× 53 0.5× 73 1.2× 28 0.7× 6 0.2× 21 250
Liv Marit Dørum Norway 7 172 1.4× 40 0.4× 90 1.4× 11 0.3× 32 1.1× 9 239
Thomas McFarlane Canada 9 125 1.0× 56 0.5× 108 1.7× 42 1.1× 5 0.2× 19 303
Tomohiro Ozaki Japan 9 127 1.0× 117 1.1× 14 0.2× 12 0.3× 8 0.3× 19 188
Solène Doat France 9 294 2.4× 159 1.5× 45 0.7× 20 0.5× 20 0.7× 24 415
G Tripsianis Greece 11 154 1.3× 194 1.8× 161 2.6× 5 0.1× 18 0.6× 14 384
Maddalena Centanni Sweden 5 225 1.9× 59 0.5× 14 0.2× 21 0.6× 16 0.5× 13 311
Dong Xing China 9 42 0.3× 124 1.1× 33 0.5× 17 0.4× 4 0.1× 23 257
Chaozheng Zhou China 7 151 1.2× 70 0.6× 14 0.2× 6 0.2× 18 0.6× 10 304
Patrick Julier United Kingdom 6 158 1.3× 70 0.6× 52 0.8× 8 0.2× 87 2.9× 9 296

Countries citing papers authored by Simon Grumett

Since Specialization
Citations

This map shows the geographic impact of Simon Grumett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Grumett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Grumett more than expected).

Fields of papers citing papers by Simon Grumett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Grumett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Grumett. The network helps show where Simon Grumett may publish in the future.

Co-authorship network of co-authors of Simon Grumett

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Grumett. A scholar is included among the top collaborators of Simon Grumett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Grumett. Simon Grumett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.
2.
Bridgewater, John, Saifee Mullamitha, Michael Braun, et al.. (2020). 502P Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes. Annals of Oncology. 31. S453–S453.
3.
Milošević, M., John Edwards, D. Tsang, et al.. (2020). Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed. Colorectal Disease. 22(10). 1314–1324. 86 indexed citations
4.
Tilby, Michaël, et al.. (2019). Trifluridine-tipiracil for the treatment of metastatic colorectal cancer patients: UK multicentre real-world experience. Annals of Oncology. 30. iv27–iv27. 2 indexed citations
5.
Swinson, Daniel, Mohan Hingorani, Jo Dent, et al.. (2019). Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial.. Journal of Clinical Oncology. 37(15_suppl). 4051–4051. 5 indexed citations
6.
Hall, Peter, Daniel Swinson, Justin S. Waters, et al.. (2019). Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.. Journal of Clinical Oncology. 37(15_suppl). 4006–4006. 39 indexed citations
7.
Openshaw, Mark R., et al.. (2013). Atypical Hypertrophic Osteoarthropathy as a Presenting Complaint in a Non-Smoker. Journal of Medical Cases. 4(4). 204–207. 1 indexed citations
8.
Ahmad, Saif, Wendi Qian, Sarah Ellis, et al.. (2013). Ipilimumab in the real world: The U.K. expanded access programme (EAP) experience in advanced melanoma.. Journal of Clinical Oncology. 31(15_suppl). 3018–3018. 4 indexed citations
9.
Rao, Ankit & Simon Grumett. (2012). Ipilimumab Associated Autoimmune Alveolitis Responding to Corticosteroids. Journal of Medical Cases. 4(1). 22–25. 2 indexed citations
10.
Midgley, Rachel, Christopher C. McConkey, Elaine Johnstone, et al.. (2010). Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial. Journal of Clinical Oncology. 28(30). 4575–4580. 67 indexed citations
11.
Grumett, Simon, et al.. (2009). Amelanotic melanoma presenting with cervical lymphadenopathy. BMJ Case Reports. 2009. bcr0620080101–bcr0620080101. 1 indexed citations
12.
Grumett, Simon, et al.. (2003). Neural Networks in the Prediction of Survival in Patients with Colorectal Cancer. Clinical Colorectal Cancer. 2(4). 239–244. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Pellegrini Breakdown of academic impact, for papers by Liv Marit Dørum Breakdown of academic impact, for papers by Thomas McFarlane Breakdown of academic impact, for papers by Tomohiro Ozaki Breakdown of academic impact, for papers by Solène Doat Breakdown of academic impact, for papers by G Tripsianis Breakdown of academic impact, for papers by Maddalena Centanni Breakdown of academic impact, for papers by Dong Xing Breakdown of academic impact, for papers by Chaozheng Zhou Breakdown of academic impact, for papers by Patrick Julier
Rankless by CCL
2026